Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Irina Alexandrovna Baldueva"'
Autor:
Anna Danilova, Galina S. Kireeva, Ye. Gubareva, Natalya Avdonkina, Irina Alexandrovna Baldueva, Anton Zozulya
Publikováno v:
Problems in oncology. 66:563-571
Circadian clock is a complex mechanism regulating many different physiological processes. Preclinical, epidemiological and clinical studies demonstrate association between circadian rhythms disruption and tumor initiation. Study of modulation of soli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b59fd71b06d8dae6b3ebc3c2c1e6e3e
https://doi.org/10.37469/0507-3758-2020-66-5-563-571
https://doi.org/10.37469/0507-3758-2020-66-5-563-571
Autor:
T. Yu. Semiglazova, Gulfiya Midhatovna Teletaeva, Vladislav Semiglazov, D. O. Yurlov, Irina Alexandrovna Baldueva, Dilorom Latipova, Svetlana Protsenko, Z. S. Kotova, Alexey Viktorovich Novik, Anna Semenova
Publikováno v:
Медицинский совет, Vol 0, Iss 10, Pp 172-175 (2018)
The aim of this study is to analyse the efficacy of efferent therapy (hemosorption) as part of drug treatment in patients with metastatic colorectal cancer (mCRC) based on the use of standard first-line chemotherapy combined with the bevacizumab bios
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83977ae8a36b1a632b44013cda438ded
https://www.med-sovet.pro/jour/article/view/2554
https://www.med-sovet.pro/jour/article/view/2554
Autor:
Dmitrii Viktorovich Girdyuk, Irina Alexandrovna Baldueva, Dilorom Khamidovna Latipova, Gulfiya Midhatovna Teletaeva, Tatyana Nekhaeva, Aleksei Viktorovich Novik, Natalia Viktorovna Emelyanova, Anna Semenova, Svetlana Protsenko
Publikováno v:
Journal of Clinical Oncology. 39:2539-2539
2539 Background: The immune system has well-known relation to tumor progression. Numerous immune-related parameters exist, but only a minor part could be used as biomarkers, especially dynamic ones. We trained a progression prediction model based on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f147b3314ecbdc10fc50b2904e04246
https://doi.org/10.1200/jco.2021.39.15_suppl.2539
https://doi.org/10.1200/jco.2021.39.15_suppl.2539
Autor:
Dilorom Khamidovna Latipova, Svetlana Protsenko, Irina Alexandrovna Baldueva, Natalya Shendaleva, Anton Zozulya, Anna Semenova, Gulfiya Midhatovna Teletaeva, Tatyana Nekhaeva, Aleksei Viktorovich Novik, Tatiana Semiglazova
Publikováno v:
Journal of Clinical Oncology. 39:e23534-e23534
e23534 Background: Immunomodulators are used in the management of patients with soft tissue sarcoma, (STS). However, the precise mechanism behind their benefits in anticancer therapy effects have yet to be determined. We assessed the impact of the im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cffc010b2de262072202b1768c98a7c4
https://doi.org/10.1200/jco.2021.39.15_suppl.e23534
https://doi.org/10.1200/jco.2021.39.15_suppl.e23534
Autor:
M. I. Sluzhev, Alexey Viktorovich Novik, Vladimir Moiseyenko, Aleksei Olegovich Danilov, Anna Semenova, Svetlana Protsenko, Georgii P. Georgiev, Tatyana Leonidovna Nehaeva, Larin Ss, Anna Danilova, Irina Alexandrovna Baldueva
Publikováno v:
Journal of Clinical Oncology. 37:e14022-e14022
e14022 Background: Immunotherapy may produce long lasting effects on survival.Magnitude of efficacy may be depended from immune factors. We evaluated the overall survival (OS) in pts treated with GMV with biomarker analysis of immunosuppressive facto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21bcd228bfe7c53c2b245371f2f6d192
https://doi.org/10.1200/jco.2019.37.15_suppl.e14022
https://doi.org/10.1200/jco.2019.37.15_suppl.e14022